Neurobehavioral Manifestations

Search with Google Search with Bing
Information
Disease name
Neurobehavioral Manifestations
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT04937452 Active, not recruiting Phase 2 Dopaminergic Therapy for Frontotemporal Dementia Patients June 3, 2021 April 1, 2024
NCT00247585 Completed Phase 2 Hangover, Congeners, Sleep and Occupational Performance September 2003 June 2006
NCT00515294 Completed Phase 1/Phase 2 Acute and Residual Effects of Caffeinated Beer October 2006 October 2009
NCT00586638 Completed N/A Training Cognitive Control Processes in Older Adults December 2007 February 2010
NCT01061242 Completed N/A Intensive Care Unit (ICU) Sleep Quality and Neurocognitive Performance January 2010 July 2010
NCT01150071 Completed Growth, Health and Development in Children Born Extremely Preterm August 2010 December 2014
NCT01782378 Completed N/A Scalp Application of LED Therapy to Improve Thinking and Memory in Veterans With Gulf War Illness January 9, 2015 August 6, 2018
NCT01953068 Completed Executive Reaction Time Test in Assessment of Cognitive Dysfunction After Aortic Valve Procedures January 2014 May 2016
NCT00183170 Completed Phase 2 Residual Effects of Intoxication on Student Performance February 2004 January 2009
NCT02557425 Completed Prophylaxis Against Malaria to Enhance Child Development (PROTECT Study) October 2015 August 5, 2021
NCT02590848 Completed N/A Walnuts, Long-Chain Polyunsaturated Fatty Acids and Adolescent Brain Development April 2016 June 5, 2019
NCT02680210 Completed N/A Self-defining Memories in Patients With a TBI February 4, 2016 May 2016
NCT02790372 Completed N/A The Effect of Case Conferencing in Nursing Homes April 2015 April 5, 2017
NCT03268590 Completed Phase 4 Neuroimaging During Pure Oxygen Breathing October 2, 2017 May 9, 2018
NCT03407729 Completed Measuring Brain Activity of School Age Children June 8, 2018 February 17, 2020
NCT03479476 Completed Phase 2/Phase 3 A Trial of Metformin in Individuals With Fragile X Syndrome April 30, 2018 May 1, 2024
NCT03574350 Completed N/A Effect on Early Somatic Growth of a Daily Kinesthetic Stimulation on Preterm Infants August 15, 2013 February 28, 2018
NCT05934422 Enrolling by invitation N/A NiPPeR Randomised Trial - Child Follow Up Study June 16, 2023 August 30, 2026
NCT06396689 Not yet recruiting N/A NapBiome: Targeting Gut Microbiota and Sleep Rhythm to Improve Developmental and Behavioral Outcomes in Early Childhood September 1, 2024 August 31, 2028
NCT05432349 Recruiting Rett Syndrome Registry August 2, 2022 July 2028
NCT03862950 Recruiting Phase 2 A Trial of Metformin in Individuals With Fragile X Syndrome (Met) May 24, 2019 June 2026
NCT04289142 Recruiting Phase 4 Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients December 1, 2019 March 2026
NCT03222375 Recruiting SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism September 26, 2017 December 2027
NCT05657860 Recruiting Phase 4 Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome December 17, 2020 January 18, 2024
NCT02501434 Suspended Phase 2 Aneurysmal Subarachnoid Hemorrhage Trial RandOmizing Heparin April 2016 January 1, 2024
NCT02306460 Terminated Frontal Cognitive Control Functions Before and After Percutaneous Catheter Procedures in Treatment of Atrial Fibrillation February 9, 2015 December 2020
NCT01506349 Terminated N/A Assessing Neurocognitive Effects of Gluten Exposure June 2015 March 2018
NCT05108207 Unknown status N/A A Software to Prevent Delirium (PREVEDEL) in Hospitalized Older Adults August 1, 2021 January 15, 2023
MeSH unique ID (MeSH (Medical Subject Headings))
D019954